Transjugular intrahepatic portosystemic shunt trends in China: A brief review

Author: Xiao JIANGQIANG ¹ ; ZhuGe YUZHENG
Author Information

1. Department of Gastroenterology, Nanjing Drum Tower Hospital, Nanjing University School of Medicine, Nanjing, China. yuzheng9111963@aliyun.com
Publication Type:Review
Keywords: China; Hypertension, portal; Incidence; Transjugular intrahepatic portosystemic shunt
MeSH: Asian Continental Ancestry Group; China; Humans; Hypertension, Portal; Incidence; Portasystemic Shunt, Surgical
From:Gastrointestinal Intervention 2018;7(1):14-17
CountryRepublic of Korea
Language:English
Abstract: Transjugular intrahepatic portosystemic shunt (TIPS) is now considered as a major treatment option for cirrhotic patients with portal hypertension. Globally, it is getting markedly increase attention, and a similar phenomenon is occurring in China. On average, the number of TIPS procedures is increasing at a rate of 15% per year. Published research papers are also continuously growing every year. Similar but unique compared to western countries, most Chinese physicians follow Chinese specialized guidelines when treating patients with portal hypertension. In this review, we briefly introduce the history of TIPS in China, the present and the future of TIPS in China.